These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29976076)

  • 1. Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases.
    Akankwasa G; Jianhua L; Guixue C; Changjuan A; Xiaosong Q
    Biomark Med; 2018 Aug; 12(8):927-935. PubMed ID: 29976076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research on the Combined Detection of Urine UmAlb and Urinary Nephrin, Podocalyxin in Podocyte of MKR Mice with Diabetic Nephropathy].
    Zeng J; Zhang X; Yu R; Tang Y; Luo WJ; Chen C; Wu YJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):722-5. PubMed ID: 26619543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
    Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K
    Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary podocyte can be an indicator for the pathogenetic condition of patients with IgA nephropathy.
    Shen P; Shen J; Li W; He L
    Clin Lab; 2014; 60(10):1709-15. PubMed ID: 25651718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
    Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
    Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
    Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
    Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary podocyte and urinary podocalyxin; markers for diabetic nephropathy].
    Takemoto M; Shoji M; Yokote K
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():181-5. PubMed ID: 27266084
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarkers of glomerular dysfunction in pre-eclampsia - A systematic review.
    Kerley RN; McCarthy C
    Pregnancy Hypertens; 2018 Oct; 14():265-272. PubMed ID: 29567337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models.
    Wada Y; Abe M; Moritani H; Mitori H; Kondo M; Tanaka-Amino K; Eguchi M; Imasato A; Inoki Y; Kajiyama H; Mimura T; Tomura Y
    Exp Biol Med (Maywood); 2016 Oct; 241(16):1865-76. PubMed ID: 27216597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of podocyte-associated molecules in acquired human kidney diseases.
    Koop K; Eikmans M; Baelde HJ; Kawachi H; De Heer E; Paul LC; Bruijn JA
    J Am Soc Nephrol; 2003 Aug; 14(8):2063-71. PubMed ID: 12874460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
    Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia.
    Wang Y; Zhao S; Loyd S; Groome LJ
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1084-9. PubMed ID: 22301621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
    Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
    J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary detection of podocyte injury.
    Camici M
    Biomed Pharmacother; 2007 Jun; 61(5):245-9. PubMed ID: 17532599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine synaptopodin excretion is an important marker of glomerular disease progression.
    Kwon SK; Kim SJ; Kim HY
    Korean J Intern Med; 2016 Sep; 31(5):938-43. PubMed ID: 27604800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of urinary podocytes and nephrin as markers for children with glomerular diseases.
    Wang P; Li M; Liu Q; Chen B; Ji Z
    Exp Biol Med (Maywood); 2015 Feb; 240(2):169-74. PubMed ID: 25245074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
    Chen LP; Zhou QL; Peng WS; Wu XY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted downregulation of extracellular nephrin in human IgA nephropathy.
    Gagliardini E; Benigni A; Tomasoni S; Abbate M; Kalluri R; Remuzzi G
    Am J Nephrol; 2003; 23(4):277-86. PubMed ID: 12853730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of urinary podocalyxin in children with IgA nephropathy].
    Okubo S
    Nihon Jinzo Gakkai Shi; 1995 Jul; 37(7):357-65. PubMed ID: 7637206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.